Sex differences in adverse events in Medicare individuals ≥ 66 years of age post glioblastoma treatment. - Dmukauskas M; Cioffi G; Waite KA; Sloan AE; Neff C; Price M; Ostrom QT; Barnholtz-Sloan JS (Journal of neuro-oncology, 2024)